HomeHome

Affiliated Lab Member

Ali Jannati, MD, PhD

Ali Jannati, MD, PhD
Postdoctoral Research Fellow

Education History:
Ph.D., Cognitive and Neural Sciences , Simon Fraser University, Vancouver, Canada
M.A., Cognitive and Neural Sciences, Simon Fraser University, Vancouver, Canada
M.D.,Tehran University of Medical Sciences, Tehran, Iran

Ali received his MD from Tehran University of Medical Sciences in Tehran, Iran, where he was involved in research studies in neurogenetics, neuropharmacology, cognitive neuroscience, and neurology. He then pursued his graduate studies in Cognitive and Neural Sciences at Simon Fraser University in Vancouver, Canada, where he studied visual attention, visual search, and masking in healthy adults using visual psychophysics, electroencephalography (EEG), and event-related potentials (ERPs).

Ali first joined the BA-CNBS as a Visiting Research Fellow in 2013, while still in graduate school, to gain experience in applications of transcranial magnetic stimulation (TMS). After completing his PhD training, he returned as a Postdoctoral Research Fellow at the BA-CNBS, where his research has been supported by fellowships from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (CIHR).

Research Interests:
Ali’s long-term interests lie in utilizing techniques in cognitive neuroscience and neurophysiology, including behavioral experiments, EEG/ERP, noninvasive brain stimulation, and functional neuroimaging to improve the understanding, diagnosis, and treatment of neuropsychiatric disorders. At present, he is working on a project that explores the utility of TMS measures of brain plasticity as a novel neurophysiologic endophenotype in high- and low-functioning adults and children with autism spectrum disorders.

Selected Publications:

  1. Jannati A,, Ryan MA, Block G, Kayarian FB, Oberman LM, Rotenberg A, Pascual-Leone A. Modulation of motor cortical excitability by continuous theta-burst stimulation in adults with autism spectrum disorder: The roles of BDNF and APOE polymorphisms. medRxiv. (in press)
  2. Jannati A, Ryan MA, Kaye HL, Tsuboyoma M, Rotenberg A. Biomarkers obtained by transcranial magnetic stimulation in neurodevelopmental disorders. J Clin Neurophys. (in press)
  3. Kayarian FB, Jannati A, Rotenberg A, Santarnecchi E. Targeting gamma-related pathophysiology in autism spectrum disorder using transcranial electrical stimulation: opportunities and challenges. Autism Res. (in press)
  4. Corp DT, Bereznicki HG, Clark GM, Youssef GJ, Fried PJ, Jannati A, et al. Large-scale analysis of interindividual variability in theta-burst stimulation data: Results from the ‘Big TMS Data Collaboration’. Brain Stim. (in press)
  5. Corp DT, Bereznicki HG, Clark GM, Youssef GJ, Fried PJ, Jannati A, et al. Large-scale analysis of interindividual variability in single and paired-pulse TMS data: Results from the 'Big TMS Data Collaboration'. Brain Stim (in press)
  6. Jannati A, Block G, Ryan MA, Kaye HL, Kayarian FB, Bashir S, Oberman LM, Pascual-Leone A, Rotenberg A. Continuous theta-burst stimulation in children with high-functioning autism spectrum disorder and typically developing children. Front Integr Neurosci. 2020;14:13. https://www.ncbi.nlm.nih.gov/pubmed/32231523/
  7. Morris TP, Davila-Pérez P, Jannati A, Menardi A, Pascual-Leone A, Fried PJ. Aftereffects of intermittent theta-burst stimulation in adjacent, non-target muscles. Neuroscience. 2019 Oct 15;418:157-165. https://www.ncbi.nlm.nih.gov/pubmed/31476358/
  8. Jannati A, Fried PJ, Block G, Oberman LM, Rotenberg A, Pascual-Leone A. Test-retest reliability of the effects of continuous theta-burst stimulation. Front Neurosci. 2019;13:447 https://www.ncbi.nlm.nih.gov/pubmed/31156361/
  9. Abellaneda-Pérez K, Vaqué-Alcázar L, Vidal-Piñeiro D, Jannati A, Solana E, Bargalló N, Santarnecchi E, Pascual-Leone A, Bartrés-Faz D. Age-related differences in default-mode network connectivity in response to intermittent theta-burst stimulation and its relationships with maintained cognition and brain integrity in healthy aging. NeuroImage. 2019 Mar;188:794-806. https://www.ncbi.nlm.nih.gov/pubmed/30472372/
  10. Davila-Pérez P*, Jannati A*, Fried PJ, Cudeiro Mazaira J, Pascual-Leone A. 2018. The effects of waveform and current direction on the efficacy and test-retest reliability of transcranial magnetic stimulation. Neuroscience. pii: S0306-4522(18)30649-3. https://www.ncbi.nlm.nih.gov/pubmed/30300705
  11. Cole EJ, Enticott PG, Oberman LM, Gwynette MF, Casanova MF, Jackson SLJ, Jannati A, McPartland JC, Naples AJ, Puts NAJ; rTMS in ASD Consensus Group. 2018. The potential of repetitive transcranial magnetic stimulation for autism spectrum disorder: A consensus statement. Biol Psychiatry. pii: S0006-3223(18)31592-0. href=https://www.ncbi.nlm.nih.gov/pubmed/30103951
  12. Jannati A, Block G, Oberman LM, Rotenberg A, Pascual-Leone A. 2017. Interindividual variability in response to continuous theta-burst stimulation in healthy adults. Clin Neurophysiol. 128(11): 2268-2278. https://www.ncbi.nlm.nih.gov/pubmed/29028501.
  13. Gomes-Osman J, Cabral DF, Hinchman C, Jannati A, Morris TP, Pascual-Leone A. 2017. The effects of exercise on cognitive function and brain plasticity - a feasibility trial. Restor Neurol Neurosci. 35(5):547-556. https://www.ncbi.nlm.nih.gov/pubmed/28984621.
  14. Fried PJ, Jannati A, Davila-Pérez P, Pascual-Leone A. 2017. Reproducibility of single-pulse, paired-pulse, and intermittent theta-burst TMS measures in healthy aging, type-2 diabetes, and Alzheimer's disease. Front Aging Neurosci. 9:263. https://www.ncbi.nlm.nih.gov/pubmed/28871222.
  15. Chang WH, Fried PJ, Saxena S, Jannati A, Gomes-Osman J, Kim YH, Pascual-Leone A. 2016. Optimal number of pulses as outcome measures of neuronavigated transcranial magnetic stimulation. Clin Neurophysiol. 127(8):2892-7. https://www.ncbi.nlm.nih.gov/pubmed/27156431.
  16. Jannati A, Teixeira PEP, Lopes GHR, Babiker-Mohamed M, Huerta R, Filier LB et al. 2016. The effects of individually tailored rTMS on hand function in chronic stroke: a protocol for an adaptive, phase II, randomized, sham-controlled clinical trial. Princip Pract Clinic Res. 1(4):128-136. http://www.ppcr.org/journal/index.php/ppcrjournal/article/view/36/31.
  17. Jannati A, McDonald JJ, Di Lollo V. 2015. Individual differences in rate of encoding predict estimates of visual short-term memory capacity (K). Can J Exp Psychol. 69(2):213-20. http://www.ncbi.nlm.nih.gov/pubmed/25774996
  18. Patten JW, Lagroix HE, Dixon P, Di Lollo V, Sager B,Jannati A, Yanko MR, Spalek TM. 2015. Escape from temporal-integration masking: the roles of visible persistence and input filtering. J Exp Psychol Hum Percept Perform. 41(2):431-40. http://www.ncbi.nlm.nih.gov/pubmed/25706767
  19. Jannati A, Spalek TM, Di Lollo V. 2013. A novel paradigm reveals the role of reentrant visual processes in object substitution masking. Atten Percept Psychophys. 75(6):1118-27. http://www.ncbi.nlm.nih.gov/pubmed/23673610
  20. Jannati A, Gaspar JM, McDonald JJ. 2013. Tracking target and distractor processing in fixed-feature visual search: Evidence from human electrophysiology. J Exp Psychol Hum Percept Perform. 39(6):1713-30. http://www.ncbi.nlm.nih.gov/pubmed/23527999
  21. McDonald JJ, Green JJ, Jannati A, Di Lollo V. 2013. On the electrophysiological evidence for the capture of visual attention. J Exp Psychol Hum Percept Perform. 39(3):849-60. http://www.ncbi.nlm.nih.gov/pubmed/23163789
  22. Lagroix HE, Spalek TM, Wyble B, Jannati A, Di Lollo V. 2012. The root cause of the attentional blink: first-target processing or disruption of input control? Atten Percept Psychophys. 74(8):1606-22. http://www.ncbi.nlm.nih.gov/pubmed/22893006
  23. Jannati A,Spalek TM, Lagroix HE, Di Lollo V. 2012. The attentional blink is not affected by backward masking of T2, T2-mask SOA, or level of T2 impoverishment. J Exp Psychol Hum Percept Perform. 38(1):161-8. http://www.ncbi.nlm.nih.gov/pubmed/22060143
  24. Jannati A, Di Lollo V. 2012. Relative blindsight arises from a criterion confound in metacontrast masking: implications for theories of consciousness. Conscious Cogn. 21(1):307-14. http://www.ncbi.nlm.nih.gov/pubmed/22051554
  25. Jannati A, Spalek TM, Di Lollo V. Neither backward masking of T2 nor task switching is necessary for the attentional blink. Psychon Bull Rev. 2011 Feb;18(1):70-5. http://www.ncbi.nlm.nih.gov/pubmed/21327367
  26. Jannati A, Spalek TM, Di Lollo V. 2011. On the labile memory buffer in the attentional blink: masking the T2 representation by onset transients mediates the AB. J Exp Psychol Hum Percept Perform. 37(4):1182-92. http://www.ncbi.nlm.nih.gov/pubmed/21517212>
  27. Togha M, Karvigh SA, Nabavi M, Moghadam NB, Harirchian MH, Sahraian MA, Enzevaei A, Nourian A, Ghanaati H, Firouznia K, Jannati A., Shekiba M. 2010. Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial. Mult Scler. 16(7):848-54. http://www.ncbi.nlm.nih.gov/pubmed/20488825
  28. Ekhtiari H, Behzadi A, Dehghani M, Jannati A, Mokri A. 2009. Prefer a cash slap in your face over credit for halva. Judgment & Decision Making, 4(7), 534-542. http://journal.sjdm.org/9610/jdm9610.pdf
  29. van Rijsbergen N, Jannati A, Treves A. 2008. Aftereffects in the perception of emotion following brief, masked adaptor faces. Open Behav Sci J. 2:36-52. http://benthamopen.com/ABSTRACT/TOBSJ-2-36
  30. Gholipour T, Riazi K, Noorian AR, Jannati A, Honar H, Doratotaj B, Nik HH, Shariftabrizi A, Dehpour AR. 2008. Seizure susceptibility alteration following reversible cholestasis in mice: Modulation by opioids and nitric oxide. Eur J Pharmacol. 580(3):322-8. http://www.ncbi.nlm.nih.gov/pubmed/18164287
  31. Riazi K, Honar H, Homayoun H, Rashidi N, Kiani S, Ebrahimkhani MR, Noorian AR, Ghaffari K, Jannati A, Dehpour AR. 2005. The synergistic anticonvulsant effect of agmatine and morphine: possible role of alpha 2-adrenoceptors. Epilepsy Res. 65(1-2):33-40. http://www.ncbi.nlm.nih.gov/pubmed/15975766
  32. Najmabadi H, Neishabury M, Sahebjam F, Kahrizi K, Shafaghati Y, Nikzat N, Jalalvand M, Aminy F, Hashemi SB, Moghimi B, Noorian AR, Jannati A, Mohammadi M, Javan K. 2003. The Iranian Human Mutation Gene Bank: a data and sample resource for worldwide collaborative genetics research. Hum Mutat. 21(2):146-50. http://www.ncbi.nlm.nih.gov/pubmed/12552562
  33. Pasalar P, Najmabadi H, Noorian AR, Moghimi B, Jannati A, Soltanzadeh A, Krefft T, Crook R, Hardy J. 2002. An Iranian family with Alzheimer's disease caused by a novel APP mutation (Thr714Ala). Neurology. 58(10):1574-5. http://www.ncbi.nlm.nih.gov/pubmed/12034808

Google Scholar Profile: https://scholar.google.com/citations?hl=en&user=frsWQLMAAAAJ